|
|
Volumn 77, Issue 11, 1996, Pages 2217-2222
|
|
Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival
a
a
NONE
(United States)
|
|
Author keywords
alpha fetoprotein; chemoembolization; hepatocellular carcinoma; prognostic features; surgery; survival
|
|
Indexed keywords
ALBUMIN;
ALPHA FETOPROTEIN;
DOXORUBICIN;
ETHIODIZED OIL;
FLUOROURACIL;
GELATIN SPONGE;
ADULT;
AGED;
ARTICLE;
ARTIFICIAL EMBOLISM;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL FEATURE;
FEMALE;
HUMAN;
LIVER CELL CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ACTUARIAL ANALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ALCOHOLISM;
ALPHA-FETOPROTEINS;
ASIA;
BOSTON;
CARCINOMA, HEPATOCELLULAR;
COMBINED MODALITY THERAPY;
COMORBIDITY;
FEMALE;
HEMOCHROMATOSIS;
HEPATITIS, VIRAL, HUMAN;
HUMANS;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM PROTEINS;
NEOPLASM STAGING;
PORTAL VEIN;
PROGNOSIS;
REGISTRIES;
REGRESSION ANALYSIS;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SERUM ALBUMIN;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
THROMBOSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0029945320
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M Document Type: Article |
|
Times cited : (340)
|
|
References (0)
|
